Carmell Therapeutics Revenue and Competitors

Location

N/A

Total Funding

Biotech

Industry

Estimated Revenue & Valuation

  • Carmell Therapeutics's estimated annual revenue is currently $2.8M per year.(i)
  • Carmell Therapeutics's estimated revenue per employee is $155,000

Employee Data

  • Carmell Therapeutics has 18 Employees.(i)
  • Carmell Therapeutics grew their employee count by -31% last year.

Carmell Therapeutics's People

NameTitleEmail/Phone
1
President/CEOReveal Email/Phone
2
Chief Quality OfficerReveal Email/Phone
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$1.4M9-10%N/AN/A
#2
$7.1M4677%N/AN/A
#3
$14.4M9327%N/AN/A
#4
$0.9M60%N/AN/A
#5
$1.6M1043%N/AN/A
#6
$11.5M746%N/AN/A
#7
$0.9M1122%N/AN/A
#8
$3.7M24-8%N/AN/A
#9
$2M1318%N/AN/A
#10
$9.3M602%N/AN/A
Add Company

What Is Carmell Therapeutics?

Carmell Therapeutics Corporation is a privately-owned biotechnology company focused on the development and commercialization of innovative Plasma-based Bioactive Materials (PBMs). These PBMs contain a concentration of natural regenerative factors that promote healing, reduce complications, and lead to healthcare savings.

keywords:N/A

N/A

Total Funding

18

Number of Employees

$2.8M

Revenue (est)

-31%

Employee Growth %

N/A

Valuation

N/A

Accelerator

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
N/A1838%$0.265M
#2
$0.6M18-40%$18M
#3
$1.6M18-33%N/A
#4
$1.6M186%N/A
#5
$1.6M180%N/A